Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Screening for High on Treatment Platelet Reactivity in Lower Extremity Arterial Endovascular Interventions
NCT04007055Phase 3Terminated
- Start
- Aug 2019
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in Peripheral Arterial Disease (PAD). Started Aug 2019; status: terminated.
02
Drugs
ticagrelor
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT04007055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04007055.